« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6
, Pages 1326-1332.e6
, December 2009
Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5− TH2 responses
References
- . Food allergy among U.S. children: trends in prevalence and hospitalizations. NCHS Data Brief. 2008;1–8
- . Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med. 2008;60:261–277
- . Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol. 2004;113:11–28
- Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206
- . Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6:531–535
- . Nutritional management of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:179–194xi
- . T-cell responses to allergens. J Allergy Clin Immunol. 2007;119:280–294
- . Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:133–143x
- . Peanut-specific B and T cell responses are correlated in peanut-allergic but not in non-allergic individuals. Clin Exp Allergy. 2008;38:1132–1139
- . Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression. J Allergy Clin Immunol. 2006;118:905–914
- . Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol. 1994;14:299–309
- . Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108:954–961
- Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci. 2006;51:1934–1941
- Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:22–31
- Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol. 2007;120:594–601
- . Detection of intracellular cytokines by flow cytometry. Curr Protoc Immunol. 2007;Unit 6.24, p 6.24.1-6.24.21
- . T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008;8:247–258
- . The influence of different stimulation conditions on the assessment of antigen-induced CD154 expression on CD4+ T cells. Cytometry A. 2008;73:1035–1042
- . Successful use of CD154 expression and intracellular cytokine staining to monitor changes in allergen-specific Th2 cells in peripheral blood of subjects in a placebo-controlled study of Tolamba (TM), a novel immunotherapeutic vaccine for ragweed allergies. J Allergy Clin Immunol. 2009;123:S144
- HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107:4781–4789
- . Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest. 2003;111:1065–1072
- . Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13. Immunity. 2005;23:89–99
- . CD4 T cells: fates, functions, and faults. Blood. 2008;112:1557–1569
- . T cell heterogeneity: firmly fixed, predominantly plastic or merely malleable?. Nat Immunol. 2008;9:450–453
- Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med. 2006;203:2865–2877
- Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004;199:1567–1575
- TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med. 2005;202:1213–1223
Supported by the National Institute of Allergy and Infectious Diseases, NIH, Intramural Research Program.
Protocol clinicaltrials.gov identifiers: NCT00084097, NCT00001756, NCT00557895.
Disclosure of potential conflict of interest: C. Prussin owned stock in Affymetrix and receives research support from NIAID/NIH. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(09)01468-7
doi: 10.1016/j.jaci.2009.09.048
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6
, Pages 1326-1332.e6
, December 2009
